And in other drug research news. This struck me as particularly pertinent with the recent passing of Chris Cornell. I love how the toxicology report there came out last week and of course was trotted around as evidence that Ativan abuse didn’t kill him. It’s like, ummm, obviously, his wife’s implication is that Ativan abuse created the mental state that lead him to kill himself, not that the drugs themselves killed him on a physiological level.
Seems like big pharma propaganda going into damage control mode there. It’d be really nice if the deaths of Prince and Cornell lead to a wider discussion of the daemonic monstrosity that is the pharmaceutical industry, but we’ll see if that happens. Here’s a question: which recent rock star died from a psilocybin, LSD, ayahuasca, DMT, or weed problem? Yep, that’d be none. From the Vancouver Sun:
“Health professionals are sounding the alarm over the heightened risk of death linked to the use of psychiatric drugs, which was highlighted in a pair of Vancouver-based studies published this month.
Benzodiazepine (BZD) is a class of psychiatric medications known as “tranquillizers” which can reduce the body’s drive to breathe and are used to treat anxiety, sleep disorders, seizures, and other conditions. They include commonly prescribed drugs such as Valium, Xanax, and Ativan.
The first of the two studies, which involved researchers from the B.C. Centre for Excellence in HIV/AIDS (BCCfE) and the University of B.C., looked at the impact of BZD use on mortality rates and established that use of BZDs was linked to a higher risk of death than illegal drugs.
“There’s a lot of research that’s been done on more traditional drugs of abuse, other illegal drugs like heroine, cocaine, amphetamines — but not a lot is known about the abuse of this kind of drug,” said Dr. Keith Ahamad, a clinician scientist with the BCCfE and an addictions physician at St. Paul’s Hospital.
The study followed a cohort of 2,802 drug users in Vancouver’s Downtown Eastside between 1996 and 2013. Participants were interviewed semi-annually over a median duration of just over five-and-a-half years each. By the end of the study, 527 (18.8 per cent) of the participants had died.
Researchers found that the mortality rate was 1.86 times higher among the drug users who used BZD, compared to those who did not. Ahamad noted that even after researchers isolated other factors that could influence mortality, such as use of other drugs, infections, and high-risk behaviours, the mortality rate remained high among BZD users.”
I hope it’s a sweet ride sir. Rest in Peace and condolences to your family.